Buscar
01/01/2022
Azathioprine therapy induces selective NK cell depletion and IFN-? deficiency predisposing to herpesvirus reactivation
Ingelfinger F., Sparano C., Bamert D., Reyes-Leiva D., Sethi A., Rindlisbacher L., Zwicky P., Kreutmair S., Widmer C.C., Mundt S., Cortés-Vicente E., Tugues S., Becher B., Schreiner B.. Azathioprine therapy induces selective NK cell depletion and IFN-? deficiency predisposing to herpesvirus reactivation. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2022; 151(1)DOI:10.1016/j.jaci.2022.09.010. PMID:36122787. IF:14.200(Q1/1D).
01/01/2022
Therapeutic Options for the Management of Pompe Disease: Current Challenges and Clinical Evidence in Therapeutics and Clinical Risk Management
Bolano-Diaz, C, Diaz-Manera, J. Therapeutic Options for the Management of Pompe Disease: Current Challenges and Clinical Evidence in Therapeutics and Clinical Risk Management. Therapeutics and Clinical Risk Management. 2022; 18DOI:10.2147/TCRM.S334232. PMID:36536827. IF:2.800(Q3/6D).
01/01/2022
The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies
Querol L.A., Hartung H.-P., Lewis R.A., van Doorn P.A., Hammond T.R., Atassi N., Alonso-Alonso M., Dalakas M.C.. The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies. Neurotherapeutics. 2022; 19(3)DOI:10.1007/s13311-022-01221-y. PMID:35378684. IF:5.700(Q1/2D).
01/01/2022
Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis Approach
Mayhew A.G., James M.K., Moore U., Sutherland H., Jacobs M., Feng J., Lowes L.P., Alfano L.N., Muni Lofra R., Rufibach L.E., Rose K., Duong T., Bello L., Pedrosa-Hernández I., Holsten S., Sakamoto C., Canal A., Sánchez-Aguilera Práxedes N., Thiele S., Siener C., Vandevelde B., DeWolf B., Maron E., Gordish-Dressman H., Hilsden H., Guglieri M., Hogrel J.-Y., Blamire A.M., Carlier P.G., Spuler S., Day J.W., Jones K.J., Bharucha-Goebel D.X., Salort-Campana E., Pestronk A., Walter M.C., Paradas C., Stojkovic T., Mori-Yoshimura M., Bravver E., Díaz-Manera J., Pegoraro E., Mendell J.R., Straub V.. Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis Approach. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.828525. PMID:35359643. IF:3.400(Q2/5D).